These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17487262)

  • 1. Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivo.
    Hou YP; Zhang YP; Song YF; Zhu CM; Wang YC; Xie GL
    Can J Physiol Pharmacol; 2007 Feb; 85(2):209-14. PubMed ID: 17487262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Inhibitory Effect of Botulinum Toxin Type A on Rat Pyloric Smooth Muscle Contractile Response to Substance P In Vitro.
    Shao YF; Xie JF; Ren YX; Wang C; Kong XP; Zong XJ; Fan LL; Hou YP
    Toxins (Basel); 2015 Oct; 7(10):4143-56. PubMed ID: 26501321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of botulinum toxin on pyloric and antral smooth muscle.
    James AN; Ryan JP; Parkman HP
    Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G291-7. PubMed ID: 12660140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation.
    Lucioni A; Bales GT; Lotan TL; McGehee DS; Cook SP; Rapp DE
    BJU Int; 2008 Feb; 101(3):366-70. PubMed ID: 18184328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation.
    Minamoto VB; Hulst JB; Lim M; Peace WJ; Bremner SN; Ward SR; Lieber RL
    Dev Med Child Neurol; 2007 Dec; 49(12):907-14. PubMed ID: 18039237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin therapy in the ovalbumin-sensitized rat.
    Wen WD; Yuan F; Wang JL; Hou YP
    Neuroimmunomodulation; 2007; 14(2):78-83. PubMed ID: 17713354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats.
    Khera M; Somogyi GT; Salas NA; Kiss S; Boone TB; Smith CP
    Urology; 2005 Jul; 66(1):208-12. PubMed ID: 15992889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain.
    Bach-Rojecky L; Lacković Z
    Croat Med J; 2005 Apr; 46(2):201-8. PubMed ID: 15849840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory Effects of Botulinum Toxin Type A on Pyloric Cholinergic Muscle Contractility of Rat.
    Zhao P; Sun HX; Chu M; Hou YP
    Chin J Physiol; 2016 Aug; 59(4):218-24. PubMed ID: 27426259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relations between the electric activity of the pyloric sphincter and activities of the stomach and duodenum].
    Papazova MP; Kortezova NI; Atanasova EA
    Fiziol Zh SSSR Im I M Sechenova; 1982 Apr; 68(4):470-7. PubMed ID: 7084510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substance P is essential for maintaining gut muscle contractility: a novel role for coneurotransmission revealed by botulinum toxin.
    Li C; Micci MA; Murthy KS; Pasricha PJ
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(10):G839-48. PubMed ID: 24699329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder.
    Rapp DE; Turk KW; Bales GT; Cook SP
    J Urol; 2006 Mar; 175(3 Pt 1):1138-42. PubMed ID: 16469640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of botulinum neurotoxin A induced muscle paresis during a critical period upon muscle and spinal cord development in the rat.
    Clowry GJ; Walker L; Davies P
    Exp Neurol; 2006 Dec; 202(2):456-69. PubMed ID: 16928374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcitonin gene-related peptide released by capsaicin suppresses myoelectrical activity of gastric smooth muscle.
    Mizuguchi S; Ohno T; Hattori Y; Kamata K; Arai K; Saeki T; Saigenji K; Hayashi I; Kuribayashi Y; Majima M
    J Gastroenterol Hepatol; 2005 Apr; 20(4):611-8. PubMed ID: 15836712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of serotonin on the myoelectrical activity of the body of the stomach, the pyloric sphincter and duodenum].
    Shemerovskiĭ KA
    Fiziol Zh SSSR Im I M Sechenova; 1988 Aug; 74(8):1178-85. PubMed ID: 3197860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on gastric emptying and weight reduction of botulinum toxin-A injection into the gastric antral layer: an experimental study in the obese rat model.
    Coskun H; Duran Y; Dilege E; Mihmanli M; Seymen H; Demirkol MO
    Obes Surg; 2005 Sep; 15(8):1137-43. PubMed ID: 16197786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis.
    Liu HT; Kuo HC
    Urology; 2007 Sep; 70(3):463-8. PubMed ID: 17905097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of pyloric interstitial cells of Cajal explains distinct peristaltic motor patterns in stomach and small intestine.
    Wang XY; Lammers WJ; Bercik P; Huizinga JD
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G539-49. PubMed ID: 15860643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth effects of botulinum toxin type A injected into masseter muscle on a developing rat mandible.
    Kim JY; Kim ST; Cho SW; Jung HS; Park KT; Son HK
    Oral Dis; 2008 Oct; 14(7):626-32. PubMed ID: 18331419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central origin of the antinociceptive action of botulinum toxin type A.
    Bach-Rojecky L; Lacković Z
    Pharmacol Biochem Behav; 2009 Dec; 94(2):234-8. PubMed ID: 19732788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.